For atrial fibrillation with stable coronary artery disease, edoxaban alone prevents more bad outcomes than edoxaban plus an antiplatelet agent
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "For Atrial Fibrillation With Stable Coronary Artery Disease, Edoxaban Alone Prevents More Bad Outcomes Than Edoxaban Plus an Antiplatelet Agent." EE+ POEM Archive, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377306/all/For_atrial_fibrillation_with_stable_coronary_artery_disease__edoxaban_alone_prevents_more_bad_outcomes_than_edoxaban_plus_an_antiplatelet_agent.
For atrial fibrillation with stable coronary artery disease, edoxaban alone prevents more bad outcomes than edoxaban plus an antiplatelet agent. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377306/all/For_atrial_fibrillation_with_stable_coronary_artery_disease__edoxaban_alone_prevents_more_bad_outcomes_than_edoxaban_plus_an_antiplatelet_agent. Accessed February 8, 2025.
For atrial fibrillation with stable coronary artery disease, edoxaban alone prevents more bad outcomes than edoxaban plus an antiplatelet agent. (2025). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377306/all/For_atrial_fibrillation_with_stable_coronary_artery_disease__edoxaban_alone_prevents_more_bad_outcomes_than_edoxaban_plus_an_antiplatelet_agent
For Atrial Fibrillation With Stable Coronary Artery Disease, Edoxaban Alone Prevents More Bad Outcomes Than Edoxaban Plus an Antiplatelet Agent [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2025. [cited 2025 February 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377306/all/For_atrial_fibrillation_with_stable_coronary_artery_disease__edoxaban_alone_prevents_more_bad_outcomes_than_edoxaban_plus_an_antiplatelet_agent.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - For atrial fibrillation with stable coronary artery disease, edoxaban alone prevents more bad outcomes than edoxaban plus an antiplatelet agent
ID - 3377306
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377306/all/For_atrial_fibrillation_with_stable_coronary_artery_disease__edoxaban_alone_prevents_more_bad_outcomes_than_edoxaban_plus_an_antiplatelet_agent
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -